FR2861M - Monoaminoxidase inhibitor drug based on hydroxyethylisoniazide. - Google Patents

Monoaminoxidase inhibitor drug based on hydroxyethylisoniazide.

Info

Publication number
FR2861M
FR2861M FR940349A FR940349A FR2861M FR 2861 M FR2861 M FR 2861M FR 940349 A FR940349 A FR 940349A FR 940349 A FR940349 A FR 940349A FR 2861 M FR2861 M FR 2861M
Authority
FR
France
Prior art keywords
hydroxyethylisoniazide
monoaminoxidase
drug based
inhibitor drug
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR940349A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Houde S A Lab
Original Assignee
Houde S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Houde S A Lab filed Critical Houde S A Lab
Priority to FR940349A priority Critical patent/FR2861M/en
Application granted granted Critical
Publication of FR2861M publication Critical patent/FR2861M/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR940349A 1963-07-04 1963-07-04 Monoaminoxidase inhibitor drug based on hydroxyethylisoniazide. Expired FR2861M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR940349A FR2861M (en) 1963-07-04 1963-07-04 Monoaminoxidase inhibitor drug based on hydroxyethylisoniazide.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR940349A FR2861M (en) 1963-07-04 1963-07-04 Monoaminoxidase inhibitor drug based on hydroxyethylisoniazide.

Publications (1)

Publication Number Publication Date
FR2861M true FR2861M (en) 1964-10-19

Family

ID=8807568

Family Applications (1)

Application Number Title Priority Date Filing Date
FR940349A Expired FR2861M (en) 1963-07-04 1963-07-04 Monoaminoxidase inhibitor drug based on hydroxyethylisoniazide.

Country Status (1)

Country Link
FR (1) FR2861M (en)

Similar Documents

Publication Publication Date Title
FR3806M (en) Medicinal product based on a derivative of quinazolone- (4).
FR3111M (en) Medicinal product based on a cysteine derivative.
FR3522M (en) Drug based on substituted benzamides.
FR3405M (en) Medicinal product based on a sulfomethyl-polymyxin.
FR3475M (en) Drug based on diphenyl-amino-ethylamine.
FR3668M (en) Drug based on substituted hydrazines.
FR3456M (en) Fluoropyrimidines based drug.
FR2831M (en) Pancreas-based drug.
FR1827M (en) Drug based on 1.5-benzo-dioxepannes.
FR3616M (en) Medicines based on cyclic amines.
FR2239M (en) Medicines based on dialkyl-aminoalkyl-piperidines.
FR3724M (en) Medicinal product based on anisoyl-3 hydroxy-4 p. methoxy-phenyl-6α-pyrone.
FR2861M (en) Monoaminoxidase inhibitor drug based on hydroxyethylisoniazide.
FR3755M (en) Drug based on new penicillins.
FR2415M (en) Drug based on substituted ethanolamines.
FR3272M (en) Drug based on substituted hydrazines.
FR3260M (en) Drug based on isopropanols.
FR3162M (en) Drug based on sulfapyrimidines.
FR3790M (en) New drugs based on 2-alkyl-4-alkylamino-6-alkoxy-s-triazines.
FR3543M (en) Medicines based on basic ketones.
FR2992M (en) Drug based on 2.4-diamino-6-hydroxymethyl-7.8-dihydro-pteridine.
FR3512M (en) Medicines based on 1-beta-d-arabinofuranosylcytosine.
FR3774M (en) Medicinal product based on new oxaza-bicyclo-alkanones.
FR3494M (en) Medicinal product based on 16α-methyl-steroids.
FR3757M (en) Medicinal product based on streptokinase.